Frontline ATRA-ATO Therapy for Acute Promyelocytic Leukemia in Japan: Results From the Prospective Multicenter FBMTG-APL2017 Trial.

Takase K, Kamimura T, Kuriyama T, Tokuyama T, Henzan H, Kikushige Y, Choi I, Imamura Y, Mori A, Ohya S, Kawano N, Yonemoto K, Harada M, Akashi K, Miyamoto T.

Open source

DOI: 10.1111/cas.70328
Published: 2026-01-21
Container: Cancer Sci
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/cas.70328,
  title = {Frontline ATRA-ATO Therapy for Acute Promyelocytic Leukemia in Japan: Results From the Prospective Multicenter FBMTG-APL2017 Trial.},
  author = {Takase K and  Kamimura T and  Kuriyama T and  Tokuyama T and  Henzan H and  Kikushige Y and  Choi I and  Imamura Y and  Mori A and  Ohya S and  Kawano N and  Yonemoto K and  Harada M and  Akashi K and  Miyamoto T.},
  year = {2026},
  journal = {Cancer Sci},
  doi = {10.1111/cas.70328},
  url = {https://doi.org/10.1111/cas.70328}
}

RIS

TY  - JOUR
TI  - Frontline ATRA-ATO Therapy for Acute Promyelocytic Leukemia in Japan: Results From the Prospective Multicenter FBMTG-APL2017 Trial.
AU  - Takase K
AU  -  Kamimura T
AU  -  Kuriyama T
AU  -  Tokuyama T
AU  -  Henzan H
AU  -  Kikushige Y
AU  -  Choi I
AU  -  Imamura Y
AU  -  Mori A
AU  -  Ohya S
AU  -  Kawano N
AU  -  Yonemoto K
AU  -  Harada M
AU  -  Akashi K
AU  -  Miyamoto T.
PY  - 2026
JO  - Cancer Sci
DO  - 10.1111/cas.70328
UR  - https://doi.org/10.1111/cas.70328
ER  -

APA

K, T., T, K., T, K., T, T., H, H., Y, K., I, C., Y, I., A, M., S, O., N, K., K, Y., M, H., K, A., & T., M. (2026). Frontline ATRA-ATO Therapy for Acute Promyelocytic Leukemia in Japan: Results From the Prospective Multicenter FBMTG-APL2017 Trial.. Cancer Sci. https://doi.org/10.1111/cas.70328

Source records

europe-pmc · retrieved 2026-09-27T08:29:14.692Z